Various vasoactive substances are involved in the regulation of the macro-and microcirculation. We have investigated if these regulators change during long-term volume therapy with human albumin (HA) or hydroxyethylstarch solution (HES) in trauma and sepsis patients. To maintain pulmonary capillary wedge pressure (PCWP) at 10-15 mm Hg, either 20% HA (HA-trauma, n:14; HA-sepsis, n:14) or 10% lowmolecular weight HES solution (HES-trauma, n:14; HES-sepsis, n:14) were infused for 5 days, otherwise patient management did not differ between the two groups (trauma/sepsis). Mean arterial pressure (MAP), heart rate (HR), PCWP and cardiac index (CI) were monitored in all patients. Liver function was assessed using the monoethylglycinexylidide (MEGX) test, and gastric intramucosal pH (pH i ) was monitored by tonometry to assess splanchnic perfusion. Plasma concentrations of vasopressin, endothelin-1, adrenaline, noradrenaline, atrial natriuretic peptide and 6-keto-prostaglandin F 1␣ were measured from arterial blood samples. All measurements were carried out on the day of admission to the intensive care unit (trauma patients) or on diagnosis of sepsis, and daily over the next 5 days at 12:00. MAP, HR and PCWP did not differ between the corresponding subgroups (trauma/sepsis). CI increased significantly more in the HES than in the HA groups. pH i and MEGX plasma concentrations did not differ in the trauma patients throughout the study. Both were lower than normal in the sepsis groups and increased more markedly in the HES than in the albumin-treated patients (P:0.05). In the trauma patients, concentrations of all vasoactive regulators were very similar in both groups. In both sepsis groups, vasopressors (vasopressin, endothelin-1, noradrenaline and adrenaline) were significantly increased above normal at baseline and decreased more markedly in HES than in HA patients. Concentrations of atrial natriuretic peptide increased only in the HA patients (from 159 (SD 31) to 215 (38) pg ml 91 on day 2). Plasma concentrations of 6-ketoprostaglandin F 1␣ decreased significantly only in the HES sepsis patients (from 112 (25) to 47 (15) pg ml
Summary
Various vasoactive substances are involved in the regulation of the macro-and microcirculation. We have investigated if these regulators change during long-term volume therapy with human albumin (HA) or hydroxyethylstarch solution (HES) in trauma and sepsis patients. To maintain pulmonary capillary wedge pressure (PCWP) at 10-15 mm Hg, either 20% HA (HA-trauma, n:14; HA-sepsis, n: 14) or 10% lowmolecular weight HES solution (HES-trauma, n:14; HES-sepsis, n: 14) were infused for 5 days, otherwise patient management did not differ between the two groups (trauma/sepsis). Mean arterial pressure (MAP), heart rate (HR), PCWP and cardiac index (CI) were monitored in all patients. Liver function was assessed using the monoethylglycinexylidide (MEGX) test, and gastric intramucosal pH (pH i ) was monitored by tonometry to assess splanchnic perfusion. Plasma concentrations of vasopressin, endothelin-1, adrenaline, noradrenaline, atrial natriuretic peptide and 6-keto-prostaglandin F 1␣ were measured from arterial blood samples. All measurements were carried out on the day of admission to the intensive care unit (trauma patients) or on diagnosis of sepsis, and daily over the next 5 days at 12:00. MAP, HR and PCWP did not differ between the corresponding subgroups (trauma/sepsis). CI increased significantly more in the HES than in the HA groups. pH i and MEGX plasma concentrations did not differ in the trauma patients throughout the study. Both were lower than normal in the sepsis groups and increased more markedly in the HES than in the albumin-treated patients (P:0.05). In the trauma patients, concentrations of all vasoactive regulators were very similar in both groups. In both sepsis groups, vasopressors (vasopressin, endothelin-1, noradrenaline and adrenaline) were significantly increased above normal at baseline and decreased more markedly in HES than in HA patients. Concentrations of atrial natriuretic peptide increased only in the HA patients (from 159 (SD 31) to 215 (38) pg ml 91 on day 2). Plasma concentrations of 6-ketoprostaglandin F 1␣ decreased significantly only in the HES sepsis patients (from 112 (25) There are various conditions such as shock, ischaemia, trauma and sepsis that exhibit flow alterations which are inadequate for tissue needs 1 . Various circulating vasoactive substances and inflammatory mediators are important in reducing perfusion in this situation. Activation of the sympathetic nervous system is a compensatory mechanism to maintain peripheral perfusion. Although this neurohumoral activation is beneficial at first, this mechanism becomes deleterious and may be involved in the poor outcome of the critically ill 2 . Recent evidence suggests that the endothelium functions not only as a passive barrier between circulating blood and tissue, but may also be involved in the regulation of microcirculatory blood flow by producing important regulators of vascular tone (e.g. prostaglandins, nitric oxide (NO), endothelins, angiotensin II) 3 . Thus regional regulation of blood flow is a balance between systemic (central) mechanisms (e.g. autonomic nervous system) and other circulating or locally active blood flow regulators.
One approach to improve perfusion in the critically ill is the use of adequate volume replacement. It is necessary not only to guarantee an adequate haemodynamic state but also to avoid microcirculatory abnormalities. Restoration of flow is an essential key for avoiding tissue ischaemia and subsequent development of multiple organ failure (MOF) 4 . Points of controversy in this area appear to be which type of solution is best suited to avoiding the sequelae of trauma or sepsis 5 6 . This controversy refers not only to the crystalloid/colloid debate, but has been widened in recent years to include a colloid/colloid debate as synthetic colloids (e.g. hydroxyethylstarch solutions) have proved to be of benefit for volume therapy in this situation 7 . In spite of higher costs, human albumin solutions are still used widely in several centres. Most studies have compared only the short-term effects of volume infusion 8 , and evaluation of the efficacy of various volume replacement regimens is not possible with this design. Serial data on the effects of long-term volume therapy with different solutions on regulators of the circulation in the critically ill are lacking. This study was designed to investigate if the type of volume replacement (human albumin vs hydroxyethylstarch) influences plasma concentrations of regulators of the circulation.
Patients and methods
After obtaining approval from the Ethics Study Board of the hospital and informed consent from closest relatives, we studied 56 patients from our surgical intensive care unit (ICU). Twenty-eight consecutive trauma patients with an injury severity score (ISS) 9 915 points and 28 patients with sepsis secondary to major surgery (non-trauma, noncardiovascular, non-neurosurgery) were prospectively included. Sepsis was defined using the guidelines of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (ACCP/SCCM) 10 , that is more than one of the following criteria: (1) ) before inclusion in the study. The time between surgery and start of the study was more than 12 h. None of the patients was in septic shock before the beginning of the study.
All patients continuously received a mixture of fentanyl and midazolam, and all were receiving controlled mechanical ventilation. a co P at 5.0-6.4 kPa throughout the study. Prospectively, patients were allocated randomly to one of the following groups: in group I, volume therapy was carried out using 10% low-molecular weight hydroxyethylstarch (HES) solution (mean molecular weight: 200 000 Da, degree of substitution 0.5 (HES-trauma, n:14; HES-sepsis, n:14); group II, 20% human albumin (HA) was infused for volume therapy (HA-trauma, n:14; HA-sepsis, n: 14) .
According to the design of the study, fluid was infused to maintain pulmonary capillary wedge pressure (PCWP) at 10-15 mm Hg. Banked blood cells (RBC) were transfused when haemoglobin (Hb) was :9 g dl 91 , fresh frozen plasma (FFP) was given only to maintain haemostasis (prothrombin time. :50%; fibrinogen :2 g litre
91
) and platelet concentrations were infused when platelet count was :30 10 9 litre
. Crystalloids (Ringer's solution) were given to all patients to compensate for fluid loss by sweating, gastric tubes, extensive urine output and as a solvent for drugs (e.g. antibiotics).
Dopamine was given in a renal dose of 3 g kg 91 min 91 to all patients. Adrenaline was given when mean arterial pressure (MAP) was :60 mm Hg and cardiac index (CI) was :2.25 litre min 91 m
92
. Noradrenaline was administered when MAP was :60 mm Hg and systemic vascular resistance (SVR) was :600 dyn s 91 cm 95 (target: MAP 970 mm Hg). All additional therapy (parenteral feeding, antibiotics, pharmacological support, ventilation) was performed according to our standard procedure of management of intensive care patients by physicians who were not involved in the study and who were blinded to the grouping of the patients (HA vs HES).
Heart rate (HR), MAP, pulmonary capillary wedge pressure (PCWP) and CI (by the thermodilution technique) were monitored in all patients.
Arterial blood samples were obtained from an indwelling arterial cannula and plasma was separated immediately and stored at 930 ЊC. Endothelin-1 (ET-1) was measured by radioimmunoassay (RIA; Biocode, Sclessin, Belgium) 11 . Sensitivity of the test kit is 0.5 pg ml
91
; cross reactivity with endothelin-1 is 100%, endothelin-2 34%, endothelin-3 64%, bigendothelin 2% and other vasoactive peptides (e.g. angiotensin I and II, bradykinin, atrial natriuretic peptide) :0.1%. Vasopressin (by RIA; Instar Corp., Stillwater, MN, USA 12 ), atrial natriuretic peptide (ANP) (by RIA; Instar Corp. 13 ), catecholamine plasma concentrations (adrenaline and noradrenaline by high-pressure liquid chromatography with combined electrochemical detection), and 6-ketoprostaglandin F1␣ (the stable but inactive endproduct of prostaglandin I2 (prostacyclin), using a commercially available enzyme immunoassay kit (TiterZyme, PerSeptive Diagnostics, Cambridge, MA, USA)) 14 were measured from plasma within 2 months after blood sampling. All data are means of duplicate measurements, and data were obtained by one investigator who was blinded to the patients (trauma/sepsis) and their grouping (HA/HES). When data differed by more than 10%, the measurement was repeated and the mean value calculated.
Gastric intramucosal pH (pHi) was measured using a nasogastric tube (Tonometer, Tonometrics, Worcester, MA, USA). An equilibration time of 60 min was used, and pHi was measured according to the guidelines of the manufacturer. Gastric pHi was calculated using the Henderson-Hasselbalch equation 15 . Liver function was assessed using the monoethylglycinexylidide (MEGX) test. MEGX was measured from arterial blood samples by high-pressure liquid chromatography before and 15 min after lignocaine 1 mg kg 91 i.v. 16 . An MEGX plasma concentration of :50 ng ml 91 was taken as indicating abnormal liver function.
All measurements were carried out on the day of admission (traumatized patients) or on the day of sepsis diagnosis (baseline values) and continued for the following 5 days at 12:00.
All variables are expressed as mean (SD). Groups were compared using the Mann-Whitney U test. One-and two-way analysis of variance (ANOVA) with repeated measures (including Scheffé's test) were used to determine the effects of group, time and group-time interactions for each variable. P:0.05 was considered significant.
Results
Patients in the two subgroups (trauma/sepsis) were similar in characteristics and intensive care therapy (table 1) . ISS, APACHE II score and outcome were similar in the corresponding groups. The number of patients who died during (early non-survivors) and after (late non-survivors) the study was comparable in the corresponding volume groups (trauma/sepsis) (table 1). All of these patients died from multiple organ dysfunction syndrome (MODS). Use of blood, FFP, amount of crystalloids and fluid balance did not differ between the groups (table 2). In both trauma and sepsis patients, significantly more HES than HA was infused during the study (table 2) . HES costs approximately £9 per 500 ml whereas HA costs approximately £45 per 100 ml. Volume replacement with HA was significantly more costly than with HES (cumulative costs: HES-trauma, £77 (13); HESsepsis, £70 (13); HA-trauma, £936 (156); HAsepsis, £869 (200)). Catecholamine support was necessary more often and in higher doses in the sepsis compared with the trauma patients, but there were no differences between the two sepsis groups. Blood and urine electrolyte concentrations, haemoglobin, temperature and renal function did not differ significantly between the two corresponding groups.
MAP, HR, PCWP, CI and pulmonary function 2 2 O O I ( a / ) P F at baseline did not differ in the trauma and sepsis groups (table 3) . CI increased significantly more in HES-than in HA-treated patients (table 3) . a / P F increased in the trauma and sepsis groups in which HES was infused, whereas it was almost unchanged in the albumin-treated patients, being significantly different compared with the corresponding HES-group at the end of the study (table 3) .
At baseline, plasma concentrations of MEGX were significantly lower in sepsis than in trauma patients (table 3). In the trauma patients, they remained almost unchanged and did not differ between the two groups. In the sepsis patients, plasma concentration of MEGX increased earlier in HES-than in HA-treated patients (table 3) .
pHi did not differ in the trauma patients throughout the study (table 3). In the sepsis patients it was (2) 14 (3) 14 (2) 14 (3) 14 (3) 14 (2) HA-trauma 10 (2) 13 (3) 13 (3) 14 (3) 13 (2) 15 (2) HES-sepsis 10 (3) 14 (2) 14 (2) 14 (3) 15 (3) 14 (1) HA-sepsis 10 (2) 14 (2) 13 (3) 13 (3) 14 (2) 15 (2) fig. 1) . Concentrations decreased to almost normal values in HES-treated patients but remained increased in both albumin groups. ET-1 plasma concentrations were within the normal range in trauma patients and did not differ between the two groups ( fig. 2) . In the sepsis patients, ET-1 plasma concentrations decreased in the HES group being significantly lower than in the albumin-treated patients at the end of the investigation.
Plasma concentrations of adrenaline and noradrenaline decreased similarly in all trauma patients .05) (figs 3, 4) . In the sepsis patients, concentrations decreased significantly only in the HES group until the end of the study. In the albumin group, adrenaline increased, whereas noradrenaline remained unchanged during the study. Atrial natriuretic factor increased similarly to greater than normal values in both sepsis groups and did not reach normal values at the end of the study (fig. 5 ). In the albumin group, plasma concentrations were increased at the start of the study and increased further (215.5 (38.9) pg ml 91 on day 2), whereas they were decreased in HES patients (131.3 (28.8) pg ml 91 on day 5). Plasma concentrations of 6-ketoprostaglandin F1␣ did not differ in the trauma groups ( fig. 6 ). In the sepsis patients, concentrations decreased more in the HES group (from 112 (25) to 47 (15) pg ml 91 ) (P:0.05 vs HA-patients).
Discussion
Both trauma and sepsis may impair vasoregulation which is needed to control the distribution of cardiac output. Current evidence suggests that systemic and endothelial-derived mediators generated in critical illness may precipitate or sustain disturbances in tissue blood supply. Microcirculatory disturbances appear to be of major importance for the development of, and progression in the pathophysiology of shock or the evolution of MOF 4 . In this situation, volume infusion is known to be therapeutic. One important objective of fluid therapy is to restore or guarantee tissue perfusion. Whether one fluid is better than another may be a result of different experimental designs and end-points of volume therapy. To understand the effects of varying fluid management it is necessary not to limit the investigation to a specific number of hours after single volume infusion. Thus we studied the effects of two different volume therapy regimens over a period of 5 days.
In our sepsis patients, plasma concentrations of important regulators of the macro-and microcirculation were significantly more altered than in our trauma groups. Vasopressin, ET1, adrenaline and noradrenaline plasma concentrations exceeded the normal range at baseline. The increased concentrations of these potent vasoconstrictors may cause microcirculatory alterations, inadequate perfusion and ultimately tissue damage. This compensatory activation of the vasopressor systems is beneficial at first, but may become deleterious. It may result in splanchnic vasoconstriction, although there is a marked increase in the need for oxygen delivery in this situation 17 . In this study, pH i differed between our sepsis (:7.30) and trauma (97.35) patients, indicating alteration in splanchnic perfusion in sepsis 18 . Also the MEGX test was reduced below the normal range (:50 ng ml 91 ) in our sepsis patients, indicating altered hepatic function, possibly because of perfusion deficits. The increased plasma concentrations of potent systemic and local vasodilators (ANP and 6-keto-prostaglandin F 1␣ ) in our sepsis patients may be regarded as a compensatory reaction to activation of the vasopressor systems.
ET-1 represents an extremely potent vasoconstrictor, which may play an important role in (regional) blood flow regulation 19 . ET-1 is released by pathophysiological states that are characterized by limitation of cardiac output or hypotension. Moreover, endotoxin directly stimulates ET-1 release in vivo and in vitro 20 . In sepsis patients, the greatest severity of disease paralleled the highest concentration of ET-1 21 . One problem with measurement of ET-1 from plasma samples is that it does not represent the actual local concentration, but appears to be a "spill over" of endothelin released by the endothelium.
The sympathetic nervous system is activated in the critically ill 22 . The increased plasma concentrations of catecholamines in this study reflected this activation. The higher plasma concentrations in our sepsis patients may also be related to the higher catecholamine support in these patients. However, inotropic support (adrenaline) and vasopressor therapy (noradrenaline) did not differ in our sepsis groups and thus cannot explain the differences between the two volume groups. ANP plays an important role in the regulation of arterial pressure and volume homeostasis. Plasma concentrations of ANP were reported to be increased significantly from normal in sepsis patients, particularly in combination with acute respiratory failure 23 . Nakae and colleagues 24 showed that 6-keto-prostaglandin F 1␣ was higher in sepsis patients who died than in those who survived, and it may serve as a marker of illness severity.
It has been shown from animal and human studies that adrenaline stimulates ANP secretion 25 , by which negative effects on the (micro-) circulation of adrenaline may be compensated. ET-1 may stimulate the release of catecholamines and renin 26 , thus possibly contributing to vasconstriction and reduced blood flow at the microcirculatory level. In contrast, ET increased circulating ANP in dogs and ANP acts as a potent inhibitor of ET synthesis. Thus ANP may function as a negative feedback regulator of ET 3 and the vasoconstrictive actions of endothelin are opposed by this vasodilator 27 . Also, prostaglandin synthesis was shown to be increased by adrenaline 28 , by which counter regulatory vasodilatation may be induced.
In our trauma patients, the choice of volume therapy did not influence either the measured regulators of the circulation, pHi or the MEGX test. This implies that volume therapy with 20% HA in these patients can be replaced easily by HES. In our sepsis patients, however, long-term volume therapy for 5 days with hydroxethylstarch solution resulted in a more beneficial influence overall on these regulators than infusion of albumin. pHi and the MEGX test improved also more markedly in the HES than in the HA group. As monitoring of pHi has been shown to be an excellent indicator of changes in splanchnic perfusion 15 18 , improved splanchnic perfusion may be assumed in HES patients. We used the MEGX test in this study to assess hepatic function because it was demonstrated in animal experiments that this test is a suitable tool for clinical evaluation and therapeutic interventions after hypovolaemic shock 16 . The increase in MEGX plasma concentrations in our sepsis patients treated with HES solution indicated compensation of possible hepatic perfusion deficits. Overall, HES-treated patients also showed better oxygenation than HA-treated patients. This may result from either improved microcirculation in the pulmonary circulation or from less shift of fluid from the intravascular to the interstitial space resulting in less extravascular lung water (EVLW).
The reasons for these differences between the two volume regimens can only be speculative at present; although fluid balance and PCWP did not differ significantly between the corresponding groups throughout the study, higher preload with subsequent improved systemic perfusion (increased CI) in the HES groups cannot be excluded as a reason for the reduction in circulating vasopressors. Beneficial rheological effects secondary to the HES solution may have improved the microcirculation and tissue perfusion and may thus have resulted in less activation of vasopressor systems. Direct effects on endothelial cells may also have played a role; 10% pentastarch (a comparable low-molecular weight HES preparation) may have influenced directly endothelial function, for example by beneficially altering endothelial cell integrity by oxygen free radical scavenging or by stabilizing fragile cell membranes 29 . In an experimental setting, Schmand and colleagues 30 found that in a group of animals which had received HES solution for volume replacement, circulating interleukin-6 (IL-6) concentrations were normalized. This is of great interest as IL-6 may be detrimental to host immune function and thus may also be involved in (micro-) circulatory abnormalities.
Changes in pulmonary function, pHi and liver function (assessed by the MEGX test) were influenced more beneficially in those patients in whom HES was infused in comparison with HA-treated patients. Survival rate during the study and thereafter was similar in the two groups. Effective fluid therapy appears to be the mainstay of managing the critically ill; however, it was not the aim of this study to clarify if the choice of fluid has an impact on patient outcome. Large studies with considerable numbers of patients must be undertaken to fully evaluate the influence of volume regimen on outcome.
